dronabinol has been researched along with Irritable Bowel Syndrome in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goyal, H; Gupta, U; May, E; Singla, U | 1 |
| Boeckxstaens, GE; Klooker, TK; Leliefeld, KE; Van Den Wijngaard, RM | 1 |
| Burton, D; Busciglio, I; Camilleri, M; Carlson, P; Szarka, LA; Wong, BS; Zinsmeister, AR | 1 |
| Burton, D; Camilleri, M; Carlson, P; Eckert, D; Ryks, M; Wong, BS; Zinsmeister, AR | 1 |
1 review(s) available for dronabinol and Irritable Bowel Syndrome
| Article | Year |
|---|---|
Role of cannabis in digestive disorders.
Topics: Abdominal Pain; Anorexia; Cannabis; Digestive System Diseases; Dronabinol; Endocannabinoids; Gastrointestinal Diseases; Gastrointestinal Motility; Humans; Inflammatory Bowel Diseases; Irritable Bowel Syndrome; Liver Cirrhosis; Medical Marijuana; Nausea; Pancreatic Diseases; Receptors, Cannabinoid; Vomiting | 2017 |
3 trial(s) available for dronabinol and Irritable Bowel Syndrome
| Article | Year |
|---|---|
The cannabinoid receptor agonist delta-9-tetrahydrocannabinol does not affect visceral sensitivity to rectal distension in healthy volunteers and IBS patients.
Topics: Adult; Analgesics, Non-Narcotic; Cannabinoid Receptor Agonists; Cross-Over Studies; Dilatation, Pathologic; Double-Blind Method; Dronabinol; Female; Humans; Hyperalgesia; Irritable Bowel Syndrome; Middle Aged; Pain Threshold; Placebos; Pressure; Rectum; Viscera; Young Adult | 2011 |
Pharmacogenetic trial of a cannabinoid agonist shows reduced fasting colonic motility in patients with nonconstipated irritable bowel syndrome.
Topics: Adolescent; Adult; Aged; Amidohydrolases; Aryl Hydrocarbon Hydroxylases; Cannabinoid Receptor Agonists; Colon; Comorbidity; Cytochrome P-450 CYP2C9; Diarrhea; Double-Blind Method; Dronabinol; Fasting; Female; Gastrointestinal Motility; Humans; Irritable Bowel Syndrome; Male; Middle Aged; Patient Compliance; Pharmacogenetics; Polymorphism, Single Nucleotide; Receptors, Cannabinoid; Young Adult | 2011 |
Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea.
Topics: Amidohydrolases; Analgesics, Non-Narcotic; Diarrhea; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Gastrointestinal Transit; Genomics; Genotype; Humans; Irritable Bowel Syndrome; Polymorphism, Single Nucleotide; Receptor, Cannabinoid, CB1 | 2012 |